Implante transcateter de valva aórtica: resultados atuais do desenvolvimento e implante de um nova prótese brasileira

Transcatheter aortic valve implantation (TAVI) is a recent technique for the treatment of patients with severe symptomatic aortic stenosis (AS), who are at high risk for

Moreover, silencing of lysil-tRNA synthetase (krs-1) using RNAi – a model of amino acid restriction [17] – increased the lifespan of N2 worms to an extent that closely resembles

Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic

The transcatheter aortic valve implantation has become a therapeutic option for patients with symptomatic severe aortic stenosis and high risk for conventional valve

Implantation was performed after valvuloplasty with balloon catheter in patients with native valve stenosis and without valvuloplasty in patients with pre-existing bioprosthesis

The introduction of balloon-expandable sutureless bioprosthesis represents a step forward and a novel device for treating intermediate- to high-risk patients with severe

Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of

Após a realização da avaliação do IVC para cada item do instrumento de validação do protocolo, a média dos valores obtidos foi: validade de conteúdo (0,96), pertinência (0,93),